What's Happening?
Noom has launched its own wearable device, the Noom Band, to integrate continuous physiological data into its metabolic health platform. This faceless, wrist-worn device, developed in partnership with Sensor Bio, will track heart rate, heart rate variability,
SpO2, sleep, and activity. The data collected will feed directly into the Noom app, aiming to provide more comprehensive insights for users. Starting in early 2027, the Noom Band will be bundled into Noom’s existing enterprise partnerships at no additional upfront cost for employer and health plan customers. Noom CEO Geoff Cook stated that the company chose to build its own device to maintain control over the user experience and avoid competition with other wearable apps. This initiative is part of Noom's broader strategy to evolve from a weight loss app into an integrated preventive care and clinical health platform, combining behavior change, virtual care, diagnostics, medications, and continuous health data.
Why It's Important?
The introduction of the Noom Band signifies a strategic shift for Noom, moving beyond its traditional app-based weight loss programs to a more holistic metabolic health approach. By providing continuous physiological data, Noom aims to improve member engagement and drive better health outcomes, particularly for those in weight management and metabolic health programs. This is crucial as less than 10% of Noom members currently use third-party wearables. The company believes that access to data on sleep, activity, and other signals will help members stay motivated by offering additional measures of progress beyond just weight. For payers and employers, Noom anticipates that the wearable will lead to higher rates of members achieving weight loss goals, potentially resulting in outcomes-based payments and a stronger return on investment for health programs.
What's Next?
The Noom Band will be integrated into Noom's enterprise partnerships starting in early 2027, offered at no additional upfront cost to employer and health plan customers. Noom plans to study the impact of the wearable on health outcomes over the next year, particularly in relation to cardiometabolic health. The company intends to participate in the Centers for Medicare and Medicaid Services’ (CMS) Advancing Chronic Care with Effective Scalable Solutions (ACCESS) model, focusing on conditions like obesity, prediabetes, and diabetes improvement. This 10-year initiative aims to integrate tech-enabled care into Medicare, providing a proving ground for Noom to demonstrate the effectiveness of its combined behavior change program and wearable. Noom is also exploring ring-based wearable options, indicating a continued investment in diverse form factors to meet user preferences.
Beyond the Headlines
Noom's move into proprietary wearable technology highlights a growing trend in the digital health sector: the convergence of behavior change platforms, telehealth, diagnostics, and continuous health monitoring. By owning the hardware and software experience, Noom seeks to create a seamless and integrated ecosystem for metabolic health management. This approach could set a new standard for how digital health companies deliver comprehensive care, emphasizing the importance of continuous data for personalized interventions. The focus on sleep data, in particular, underscores a recognition of its critical role in metabolic health, often overlooked in traditional weight loss programs. This development also raises questions about data privacy and the ethical implications of continuous physiological monitoring, as well as the potential for such integrated platforms to reduce healthcare costs by preventing chronic diseases.













